2018 Packaging Pharmaceutical Manufacturing 
Pharmaceutical Technology
JUNE 20, 2025
June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook In March 2018, Health Canada approved Novartis’ therapy to treat individuals with HR+/HER2- advanced or metastatic breast cancer. In March 2018, Health Canada approved the therapy to treat individuals with HR+/HER2- advanced or metastatic breast cancer.
Pharmaceutical Technology
NOVEMBER 21, 2022
However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
NOVEMBER 21, 2022
However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).
European Pharmaceutical Review
DECEMBER 21, 2022
2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Environ Sci Technol 2018, 52, 4, 1725–1734 [link].
European Pharmaceutical Review
AUGUST 10, 2023
Amidst numerous warning letters distributed by the US Food and Drug Administration (FDA) to pharmaceutical manufacturers in recent months, in July this year, the US regulatory body published its analysis on drug product quality in 2022. Eight FDA warning letters were handed to European companies in 2018. Edge Biologicals Inc.,
Quality Matters
OCTOBER 13, 2021
In addition to standards for active pharmaceutical ingredients, USP also develops standards for the inactive ingredients (excipients) and other raw materials used in drug manufacturing. In a 2019 report on drug shortages, the FDA found that 62% of drug shortages occur because of quality issues in manufacturing.
Expert insights. Personalized for you.
Let's personalize your content